FibroGen Company
FibroGen, Inc. is a leading science-based biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics. The company applies its pioneering expertise in fibrosis and hypoxia-inducible factor (HIF) biology and clinical development to advance innovative medicines for the treatment of anemia, fibrotic disease, and cancer.
Investors
Headquarters:
United States
Employee Number:
251-500
Founded Date:
1993
Investment Stage:
N/A
Technology:
Drug Delivery
Estimated Revenue:
$10M to $50M
Investor Type:
N/A
Number Of Exists:
N/A
Industry:
Genomic and Epigenominc Instabillity
Funding Status:
IPO